Details for New Drug Application (NDA): 215971
✉ Email this page to a colleague
NDA 215971 describes DEUTETRABENAZINE, which is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA. Additional details are available on the DEUTETRABENAZINE profile page.
The generic ingredient in DEUTETRABENAZINE is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.
The generic ingredient in DEUTETRABENAZINE is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.
Summary for 215971
| Tradename: | DEUTETRABENAZINE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | deutetrabenazine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 6MG | ||||
| Approval Date: | Dec 26, 2024 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 9MG | ||||
| Approval Date: | Dec 26, 2024 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12MG | ||||
| Approval Date: | Dec 26, 2024 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
